Coherus Oncology Inc —— 现金流量表 (NASDAQ:CHRS) | MetaTrader

展开完整图表完整图表

Financials

概览声明统计

每季度年度

经营活动产生的现金 154.15 M-37.43 M-241.12 M-174.88 M-20.44 M-138.51 M -170.57 M 投资活动产生的现金 -14.4 M-138.41 M-166.85 M144.64 M230.32 M375.09 M 423.23 M 融资活动产生的现金 223.95 M51.88 M54.33 M69.6 M-186.97 M-273.7 M -219.85 M 自由现金流 154.15 M-37.43 M-241.12 M-174.88 M-20.44 M-138.51 M -170.57 M

新闻

Coherus Oncology: Setting Up For Important Readouts In Mid-2026 (NASDAQ:CHRS)

Coherus Oncology (CHRS) Reports Q1 Loss, Lags Revenue Estimates

Are Medical Stocks Lagging AnaptysBio (ANAB) This Year?

Is Brookdale Senior Living (BKD) Outperforming Other Medical Stocks This Year?

Is Biodesix (BDSX) Stock Outpacing Its Medical Peers This Year?

Coherus BioSciences在Citizens大会上展示战略性肿瘤学转型

Coherus BioSciences at The Citizens Conference: Strategic Oncology Shift

Oppenheimer重申Coherus Biosciences股票评级为跑赢大盘

Oppenheimer reiterates Coherus Biosciences stock rating at Outperform

Coherus Oncology, Inc. (CHRS) Q4 2025 Earnings Call Transcript

Coherus Oncology (CHRS) Reports Q4 Loss, Misses Revenue Estimates

Coherus BioSciences Q1 每股收益与预期持平, 营收低于预期